Together, these studies suggest that augmented TNF signalling may be key in COVID19 and may provide a potential therapeutic target through the use of neutralizing antibodies or small molecule inhibitors as has been previously suggested [5, 39]. The gene discussed is TNF; the disease is COVID-19.